Drug intelligence / Profile preview

Dante's Pure Hemp Oil

Development stage: Unknown
Lead developer: Kannaway
Modality: Small Molecules
Administration: Oral

Overview

Dante's Pure Hemp Oil is a THC-free cannabidiol (CBD) product specifically formulated for pets, developed by Kannaway, a subsidiary of Medical Marijuana, Inc. The product contains 1000 mg of CBD derived from hemp, blended with medium-chain triglyceride (MCT) oil. As a botanical extract, it retains naturally occurring terpenes and essential fatty acids. It is marketed as a wellness supplement for animals, emphasizing safety and consistency through a 'Triple Lab Tested' process. While not intended to treat specific medical conditions under FDA guidelines, it is positioned within the veterinary nutraceutical market for general health support.

Brand names: Dante's Pure Hemp Oil

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Dante's Pure Hemp Oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dante's Pure Hemp Oil.

Explore the full profile